ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,681Medicare Part D Prescriptions Filled, Including Refills

Rank: 43 out of 749

$668K Total Retail Price of All Prescriptions

Rank: 79 out of 749

287 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

21% of this provider’s 287 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

2% of this provider’s 5,872 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 31%.

Prescription Price

$87 was the average price of a prescription from this provider, compared to $116 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 487 393 1 1
SIMVASTATIN 263 227 2 5
FUROSEMIDE 255 208 3 2
RENVELA 240 159 4 3
HYDROCODONE-ACETAMINOPHEN 204 109 S3 5 12
METFORMIN HCL 171 128 6 22
PROSOL 170 170 7 48
CARVEDILOL 166 146 8 11
LISINOPRIL 159 130 9 4
GABAPENTIN 144 122 10 25
PANTOPRAZOLE SODIUM 142 104 11 30
CLONIDINE HCL 139 104 12 15
ZOLPIDEM TARTRATE 133 131 13 24
LEVOTHYROXINE SODIUM 129 97 14 13
DIOVAN 124 114 15 14
HYDROCHLOROTHIAZIDE 123 111 16 27
SENSIPAR 113 58 17 8
OMEPRAZOLE 112 106 18 6
ENALAPRIL MALEATE 110 88 19 62
AZITHROMYCIN 101 80 20 65
CLOPIDOGREL 100 78 21 42
ATORVASTATIN CALCIUM 96 82 22 18
WARFARIN SODIUM 95 81 23 31
NAPROXEN 95 93 23 160
GLIPIZIDE 93 65 25 32
RENAGEL 87 75 26 50
INSULIN SYRINGE 81 45 27 41
POTASSIUM CHLORIDE 78 45 28 37
PLAVIX 76 61 29 56
METOPROLOL TARTRATE 75 58 30 7
MEGESTROL ACETATE 73 64 R 31 69
GLYBURIDE 71 55 R 32 103
ALLOPURINOL 69 36 33 10
ISOSORBIDE MONONITRATE ER 69 51 33 45
IBUPROFEN 60 27 35 118
ATENOLOL 59 41 36 20
PRANDIN 56 55 37 148
METOPROLOL SUCCINATE 55 32 38 26
LOSARTAN POTASSIUM 55 17 38 9
PREDNISONE 54 35 40 28
LIPITOR 54 31 40 71
DIPHENOXYLATE-ATROPINE 54 35 40 177
DONEPEZIL HCL 51 50 43 55
LEVETIRACETAM 50 24 44 149
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 30, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.